相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pregnane X receptor mediates sorafenib resistance in advanced hepatocellular carcinoma
Fan Feng et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2018)
Macrovipecetin, a C-type lectin from Macrovipera lebetina venom, inhibits proliferation migration and invasion of SK-MEL-28 human melanoma cells and enhances their sensitivity to cisplatin
Manel B. Hammouda et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2018)
Baicalein sensitizes hepatocellular carcinoma cells to 5-FU and Epirubicin by activating apoptosis and ameliorating P-glycoprotein activity
Jun Li et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Tumor Architecture and Notch Signaling Modulate Drug Response in Basal Cell Carcinoma
Markus Eberl et al.
CANCER CELL (2018)
Transcriptional Regulation of the Warburg Effect in Cancer by SIX1
Ling Li et al.
CANCER CELL (2018)
Radiofrequency Ablation Versus Stereotactic Body Radiotherapy for Localized Hepatocellular Carcinoma in Nonsurgically Managed Patients: Analysis of the National Cancer Database
Devalkumar J. Rajyaguru et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
A new apatinib microcrystal formulation enhances the effect of radiofrequency ablation treatment on hepatocellular carcinoma
Hui Xie et al.
ONCOTARGETS AND THERAPY (2018)
Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study
Devin Razavi-Shearer et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2018)
Ectodomain shedding of the cell adhesion molecule Nectin-4 in ovarian cancer is mediated by ADAM10 and ADAM17
Petra C. Buchanan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Starting Dose of Sorafenib for the Treatment of Hepatocellular Carcinoma: A Retrospective, Multi-Institutional Study
Kim A. Reiss et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Terfenadine combined with epirubicin impedes the chemo-resistant human non-small cell lung cancer both in vitro and in vivo through EMT and Notch reversal
Li An et al.
PHARMACOLOGICAL RESEARCH (2017)
Targeting ADAM17 inhibits human colorectal adenocarcinoma progression and tumor-initiating cell frequency
Joseph Dosch et al.
ONCOTARGET (2017)
Current advances in the elimination of hepatitis B in China by 2030
Shuye Zhang et al.
FRONTIERS OF MEDICINE (2017)
New knowledge of the mechanisms of sorafenib resistance in liver cancer
Yan-jing Zhu et al.
ACTA PHARMACOLOGICA SINICA (2017)
Evolution of Cancer Stem-like Cells in Endocrine-Resistant Metastatic Breast Cancers Is Mediated by Stromal Microvesicles
Pasquale Sansone et al.
CANCER RESEARCH (2017)
Nucleostemin/GNL3 promotes nucleolar polyubiquitylation of p27kiP1 to drive hepatocellular carcinoma progression
Baoying Hu et al.
CANCER LETTERS (2017)
Hepatocellular carcinoma (HCC): beyond sorafenib-chemotherapy
Dae Won Kim et al.
JOURNAL OF GASTROINTESTINAL ONCOLOGY (2017)
A phase Ib study of selumetinib (AZD6244, ARRY-142886) in combination with sorafenib in advanced hepatocellular carcinoma (HCC)
W. M. Tai et al.
ANNALS OF ONCOLOGY (2016)
Sorafenib with or without everolimus in patients with advanced hepatocellular carcinoma (HCC): a randomized multicenter, multinational phase II trial (SAKK 77/08 and SASL 29)aEuro
D. Koeberle et al.
ANNALS OF ONCOLOGY (2016)
Rhamnetin induces sensitization of hepatocellular carcinoma cells to a small molecular kinase inhibitor or chemotherapeutic agents
Hui Jia et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2016)
A combination of sorafenib and SC-43 is a synergistic SHP-1 agonist duo to advance hepatocellular carcinoma therapy
Tzu-I Chao et al.
CANCER LETTERS (2016)
Leptin-induced transphosphorylation of vascular endothelial growth factor receptor increases Notch and stimulates endothelial cell angiogenic transformation
Viola Lanier et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2016)
Randomized Trial of Hepatic Artery Embolization for Hepatocellular Carcinoma Using Doxorubicin-Eluting Microspheres Compared With Embolization With Microspheres Alone
Karen T. Brown et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Regorafenib for the Treatment of Advanced Gastric Cancer (INTEGRATE): A Multinational Placebo-Controlled Phase II Trial
Nick Pavlakis et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial
Naomi B. Haas et al.
LANCET (2016)
Requirements for global elimination of hepatitis B: a modelling study
Shevanthi Nayagam et al.
LANCET INFECTIOUS DISEASES (2016)
Design, Synthesis and Biological Evaluation of Novel Benzothiazole Derivatives as Selective PI3Kβ Inhibitors
Shuang Cao et al.
MOLECULES (2016)
Discovery of an enzyme and substrate selective inhibitor of ADAM10 using an exosite-binding glycosylated substrate
Franck Madoux et al.
SCIENTIFIC REPORTS (2016)
Notch signaling: An emerging therapeutic target for cancer treatment
Xun Yuan et al.
CANCER LETTERS (2015)
MiRNA153 Reduces Effects of Chemotherapeutic Agents or Small Molecular Kinase Inhibitor in HCC Cells
Yan Chen et al.
CURRENT CANCER DRUG TARGETS (2015)
Multicenter Randomized Controlled Trial of Percutaneous Cryoablation Versus Radiofrequency Ablation in Hepatocellular Carcinoma
Chunping Wang et al.
HEPATOLOGY (2015)
HPIP is upregulated in colorectal cancer and regulates colorectal cancer cell proliferation, apoptosis and invasion
Yingying Feng et al.
Scientific Reports (2015)
The Global Burden of Liver Disease: The Major Impact of China
Fu-Sheng Wang et al.
HEPATOLOGY (2014)
Pretreatment MicroRNA Level and Outcome in Sorafenib-treated Hepatocellular Carcinoma
Benedek Gyoengyoesi et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2014)
MicroRNA-34a Targets Bcl-2 and Sensitizes Human Hepatocellular Carcinoma Cells to Sorafenib Treatment
Fan Yang et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2014)
Rhamnetin and Cirsiliol Induce Radiosensitization and Inhibition of Epithelial-Mesenchymal Transition (EMT) by miR-34a-mediated Suppression of Notch-1 Expression in Non-small Cell Lung Cancer Cell Lines
JiHoon Kang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Phase I Pharmacologic and Pharmacodynamic Study of the Gamma Secretase (Notch) Inhibitor MK-0752 in Adult Patients With Advanced Solid Tumors
Ian Krop et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
Ann-Lii Cheng et al.
LANCET ONCOLOGY (2009)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Notch-1 associates with IKKα and regulates IKK activity in cervical cancer cells
L. L. Song et al.
ONCOGENE (2008)
Conformal radiation therapy for portal vein tumor thrombosis of hepatocellular carcinoma
Ryo Toya et al.
RADIOTHERAPY AND ONCOLOGY (2007)
External beam radiation therapy for hepatocellular carcinoma: Potential of intensity-modulated and image-guided radiation therapy
M Fuss et al.
GASTROENTEROLOGY (2004)
Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival
JM Llovet et al.
HEPATOLOGY (2003)
Partial irradiation of the liver
LA Dawson et al.
SEMINARS IN RADIATION ONCOLOGY (2001)
分享论文
